Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder

PURPOSE: To assess the safety and efficacy of gemcitabine and cisplatin as neoadjuvant chemotherapy followed by selective bladder preservation chemoradiotherapy in muscle-invasive bladder cancer (MIBC). MATERIALS AND METHODS: Patients with clinical T2-T4aN0M0 MIBC eligible for radical cystectomy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Hyun Hwan, Kim, Hana, Kim, Ryul, Kim, Chan Kyo, Kwon, Ghee Young, Park, Won, Song, Wan, Jeong, Byong Chang, Park, Se Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902424/
https://www.ncbi.nlm.nih.gov/pubmed/35244990
http://dx.doi.org/10.4111/icu.20210407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902424/
https://www.ncbi.nlm.nih.gov/pubmed/35244990
http://dx.doi.org/10.4111/icu.20210407

Ejemplares similares